| Literature DB >> 31884967 |
Wenzhe Sun1, Guo Li1, Ziqiang Liu2, Jinfeng Miao1, Zhaoxia Yang3, Qiao Zhou2, Run Liu1, Suiqiang Zhu4, Zhou Zhu5.
Abstract
BACKGROUND: Large hemispheric infarction (LHI) is a severe form of stroke with high mortality and disability rates. The purpose of this study was to explore predictive indicators of the in-hospital mortality of LHI patients treated conservatively without decompressive hemicraniectomy.Entities:
Keywords: In-hospital mortality; Inflammation; Large hemispheric infarction; Neutrophil-to-lymphocyte ratio; Nomogram
Mesh:
Year: 2019 PMID: 31884967 PMCID: PMC6935484 DOI: 10.1186/s12883-019-1571-4
Source DB: PubMed Journal: BMC Neurol ISSN: 1471-2377 Impact factor: 2.474
Fig. 1Enrollment flow chart of study cohort
Patient demographics, laboratory information and radiologic characteristics (n = 158)
| parameter | All ( | Survival ( | Death ( |
|---|---|---|---|
| Age (years) | 61 (53~71) | 58 (50~68) | 68 (60~75) |
| Female (%) | 52 (32.9) | 31 (31) | 21 (36.2) |
| Smoke (%) | 80 (50.6) | 51 (51) | 29 (50) |
| Alcohol (%) | 63 (39.9) | 43 (43) | 20 (34.5) |
| ECASS-II>2 (%) | 13 (8.2) | 5 (5) | 8 (13.8) |
| Acute Intervention (%) | 38 (24.1) | 23 (23) | 15 (25.9) |
| MLS (mm) | 2.5 (0~5.9) | 0 (0~4.0) | 6.0 (1.4~10.5) |
| Baseline temperature (°C) | 36.5 (36.4~36.8) | 36.5 (36.3~36.8) | 36.5 (36.5~37) |
| SBP (mmHg) | 145 (126~165) | 146 (126~166) | 145 (126~159) |
| DBP (mmHg) | 82 (74~93) | 83 (72~95) | 80 (74~91) |
| GLU (mmol/L) | 6.2 (5.5~7.6) | 5.9 (5.4~6.8) | 7.1 (5.9~9.2) |
| HbA1c (%) | 5.7 (5.3~6.2) | 5.6 (5.3~6.1) | 5.8 (5.3~6.4) |
| hs-CRP (mg/L) | 11.1 (3.4~30.2) | 8.4 (2.6~20.9) | 15.9 (5.2~45.6) |
| NLR | 5.9 (4.3~10.2) | 5.2 (3.8~7.8) | 8.6 (5.4~14.6) |
| TG (mmol/L) | 1.1 (0.8~1.52) | 1.0 (0.7~1.6) | 1.2 (0.9~1.4) |
| HDL (mmol/L) | 1.2 (0.9~1.4) | 1.2 (0.9~1.4) | 1.2 (1.0~1.3) |
| LDL (mmol/L) | 2.7 (2.2~3.3) | 2.6 (2.2~3.3) | 2.7 (2.2~3.3) |
ECASS-II European Cooperative Acute Stroke Study-II classification, MLS midline shift, SBP baseline systolic pressure, DBP baseline diastolic pressure, GLU baseline blood glucose, HbA1c glycated hemoglobin, hs-CRP high sensitivity C-reactive protein, NLR Neutrophil to lymphocyte ratio, TG Triglyceride, HDL high-density lipoprotein, LDL low density lipoprotein
Univariate logistic regression analysis for in-hospital mortality
| parameter | β | SE | OR (95% CI) | |
|---|---|---|---|---|
| Age | 0.061 | 0.015 | < 0.001* | 1.063 (1.033~1.095) |
| Gender (Female) | 0.234 | 0.348 | 0.502 | 1.263 (0.638~2.501) |
| Smoke | − 0.040 | 0.330 | 0.904 | 0.961 (0.503~1.835) |
| Alcohol | −0.360 | 0.342 | 0.293 | 0.698 (0.357~1.364) |
| ECASS-II>2 | 1.112 | 0.596 | 0.062* | 3.040 (0.945~9.782) |
| Acute Intervention | 0.115 | 0.383 | 0.685 | 1.168 (0.457~2.484) |
| MLS | 0.252 | 0.055 | <0.001* | 1.287 (1.155~1.434) |
| Baseline temperature | 0.315 | 0.321 | 0.326 | 1.370 (0.731~2.570) |
| SBP | −0.006 | 0.007 | 0.380 | 0.994 (0.982~1.007) |
| DBP | −0.006 | 0.010 | 0.568 | 0.994 (0.974~1.014) |
| GLU | 0.272 | 0.078 | 0.001* | 1.312 (1.126~1.529) |
| HbA1c | 0.033 | 0.108 | 0.763 | 1.033 (0.836~1.277) |
| hs-CRPa | 0.298 | 0.113 | 0.008* | 1.347 (1.080~1.680) |
| NLRa | 1.311 | 0.310 | < 0.001* | 3.710 (2.020~6.814) |
| TG | −0.157 | 0.230 | 0.494 | 0.854 (0.544~1.341) |
| HDL | −0.329 | 0.510 | 0.518 | 0.719 (0.265~1.955) |
| LDL | −0.046 | 0.183 | 0.802 | 0.955 (0.667~1.368) |
*Variables with P < 0.10 in univariate analysis were included in multivariable logistic regression models for adjustment
aThese variables were transformed into log scale.
ECASS-II European Cooperative Acute Stroke Study-II classification, MLS midline shift, SBP baseline systolic pressure, DBP baseline diastolic pressure, GLU baseline blood glucose, HbA1c glycated hemoglobin, hs-CRP high sensitivity C-reactive protein, NLR neutrophil to lymphocyte ratio, TG Triglyceride, HDL high-density lipoprotein, LDL low density lipoprotein, OR odds ratio, CI confidence interval, SE standard error
Multivariate logistic regression model for in-hospital mortality
| parameter | β | SE | OR (95% CI) | |
|---|---|---|---|---|
| Age | 0.064 | 0.020 | 0.001* | 1.066 (1.025~1.108) |
| ECASS-II > 2 | −0.445 | 0.922 | 0.630 | 0.641 (0.105~3.908) |
| MLS | 0.285 | 0.062 | <0.001* | 1.330(1.177~1.503) |
| GLU | 0.132 | 0.085 | 0.121 | 1.141 (0.966~1.349) |
| hs-CRPa | 0.129 | 0.151 | 0.393 | 1.138 (0.846~1.531) |
| NLRa | 1.200 | 0.391 | 0.002* | 3.319 (1.542~7.144) |
*Statistically significant at p < 0.05 level, two-sided;
aThese variables were transformed into log scale.
ECASS-II European Cooperative Acute Stroke Study-II classification, MLS midline shift, GLU baseline blood glucose, hs-CRP high sensitivity C-reactive protein, NLR neutrophil to lymphocyte ratio, OR Odds Ratio, CI confidence Interval, SE standard error
Fig. 2a. Discriminative ability presented as receiver operating curves of predictors; b Comparison of predictive power between NLR and conventional inflammatory markers in the prediction of in-hospital death. MLS: midline shift; NLR: Neutrophil to lymphocyte ratio; hs-CRP: high sensitivity C-reactive protein, ‡These variables were transformed into log scale
Fig. 3a Nomogram of the study population to predict in-hospital death in patients with LHI; b: ROC curve of the nomogram used for predicting in-hospital mortality in patients with LHI. The area under curve was 0.858 (95% CI, 0.794~0.908); c: Calibration curves for in-hospital mortality, which are representative of predictive accuracy. MLS: midline shift; NLR: neutrophil-to-lymphocyte ratio